Paragon Care Management

Management criteria checks 2/4

Paragon Care's CEO is John Walstab, appointed in Oct 2023, has a tenure of less than a year. total yearly compensation is A$574.70K, comprised of 86.3% salary and 13.7% bonuses, including company stock and options. directly owns 19.46% of the company’s shares, worth A$42.25M. The average tenure of the management team and the board of directors is 1.6 years and 6 years respectively.

Key information

John Walstab

Chief executive officer

AU$574.7k

Total compensation

CEO salary percentage	86.3%
CEO tenure	less than a year
CEO ownership	19.5%
Management average tenure	1.6yrs
Board average tenure	6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has John Walstab's remuneration changed compared to Paragon Care's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	AU$10m
Sep 30 2023	n/a	n/a	AU$12m
Jun 30 2023	AU$575k	AU$496k	AU$13m
Dec 31 2022	n/a	n/a	AU$6m
Sep 30 2022	n/a	n/a	AU$6m
Jun 30 2022	AU$308k	AU$110k	AU$6m

Compensation vs Market: John's total compensation ($USD373.64K) is about average for companies of similar size in the Australian market ($USD293.70K).

Compensation vs Earnings: John's compensation has increased by more than 20% in the past year.

CEO

John Walstab (60 yo)

less than a year

Tenure

AU$574,703

Compensation

Mr. John Andrew Walstab serves as Executive Director of Paragon Care Limited since February 16, 2022 and served as its Executive General Manager of Paragon Care Asia since February 16, 2022 until 2023 and...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
John Walstab	Group CEO	less than a year	AU$574.70k	19.46% A$ 42.2m
Josephine Martino	Chief Financial Officer	1.6yrs	AU$444.19k	no data
Melanie Leydin	Joint Company Secretary	no data	no data	no data
Claire Newstead-Sinclair	Joint Company Secretary	1.8yrs	no data	no data

1.6yrs

Average Tenure

Experienced Management: PGC's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
John Walstab	Group CEO	2.3yrs	AU$574.70k	19.46% A$ 42.2m
Shane Tanner	Independent Non-Executive Chairman	19.3yrs	AU$150.00k	0.19% A$ 422.2k
Geoffrey Sam	Non-Executive Independent Director	7.9yrs	AU$75.00k	0.40% A$ 863.7k
Brent Stewart	Independent Non-Executive Director	6yrs	AU$75.00k	0.56% A$ 1.2m
Alan McCarthy	Non-Executive Director	2.3yrs	AU$75.00k	no data

6.0yrs

Average Tenure

69yo

Average Age

Experienced Board: PGC's board of directors are considered experienced (6 years average tenure).

Paragon Care Management

Management criteria checks 2/4

Key information

Recent management updates

Paragon Care Limited, Annual General Meeting, Nov 21, 2023

Paragon Care Limited Announces CEO Changes

Group CEO recently bought AU$201k worth of stock

Less than half of directors are independent

Group CEO recently bought AU$325k worth of stock

Paragon Care Limited, Annual General Meeting, Nov 23, 2022

Recent updates

New minor risk - Share price stability

First half 2024 earnings released: EPS: AU$0.004 (vs AU$0.008 in 1H 2023)

Paragon Care Reportedly Taps Rothschild for Defence Amid Buyout Talk

EBOS Reportedly Runs Eye over Paragon Care after Abandoning Greencross Pursuit

Paragon Care Limited, Annual General Meeting, Nov 21, 2023

Paragon Care Limited Announces CEO Changes

Paragon Care Limited Declares Fully Franked Dividend in Respect of the Financial Year Ended 30 June 2023, to Be Paid on 6 October 2023

Full year 2023 earnings released: EPS: AU$0.02 (vs AU$0.015 in FY 2022)

New minor risk - Market cap size

Paragon Care Limited to Report Fiscal Year 2023 Results on Aug 30, 2023

Group CEO recently bought AU$201k worth of stock

New minor risk - Market cap size

First half 2023 earnings released: EPS: AU$0.008 (vs AU$0.016 in 1H 2022)

Paragon Care Limited to Report First Half, 2023 Results on Feb 22, 2023

Less than half of directors are independent

Group CEO recently bought AU$325k worth of stock

Paragon Care Limited, Annual General Meeting, Nov 23, 2022

Paragon Care Limited Announces Resignation of Mark Simari as Director

Paragon Care Limited Announces Chief Financial Officer Changes

Less than half of directors are independent

Paragon Care Limited (ASX:PGC) agreed to acquire Specialist Medical Supplies Pty Ltd AUD 15.5 million.

Full year 2022 earnings released: EPS: AU$0.015 (vs AU$0.025 in FY 2021)

Paragon Care Limited Declares Fully Franked Final Dividend for the Financial Year Ended 30 June 2022, Payable on 4 October 2022

Paragon Care Limited Announces Executive Changes

Now 21% undervalued after recent price drop

Non-Executive Independent Director recently bought AU$74k worth of stock

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Paragon Care Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 26, 2022

Paragon Care Limited Announces Board Appointments

Paragon Care Limited (ASX:PGC) completed the acquisition of Quantum Health Group Limited (ASX:QTM).

Upcoming dividend of AU$0.01 per share

Non-Executive Director Xinzhou Li has left the company

Full year 2021 earnings released: EPS AU$2.45 (vs AU$0.21 loss in FY 2020)

First half 2021 earnings released: EPS AU$0.015 (vs AU$0.004 in 1H 2020)

New 90-day high: AU$0.28

Paragon Care Limited Announces Appointment of Xinzhou Paul Li (Mr Paul Li) as Non-Executive Director

Independent Non-Executive Director recently bought AU$51k worth of stock

New 90-day high: AU$0.20

Paragon Care Limited(ASX:PGC) dropped from S&P/ASX Emerging Companies Index

Full year earnings released - AU$0.21 loss per share

Paragon Care Limited(ASX:PGC) dropped from S&P/ASX All Ordinaries Index

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Board Members

Average Tenure

Average Age